Copyright
©The Author(s) 2016.
World J Clin Oncol. Feb 10, 2016; 7(1): 87-97
Published online Feb 10, 2016. doi: 10.5306/wjco.v7.i1.87
Published online Feb 10, 2016. doi: 10.5306/wjco.v7.i1.87
Dexrazoxane as an antidote to anthracyclines extravasation has level III-B evidence[16] |
Hyaluronidaseas an antidote to vinca-alkaloids and to taxanes extravasation has level V-C evidence[16] |
Topical DMSO (99%) as an antidote to anthracycline extravasation and to Mytomicin C has level IV-B evidence[16] |
Sodium thiosulfate as an antidote to mechlorethamine extravasation has level V-C evidence[16] |
- Citation: Kreidieh FY, Moukadem HA, El Saghir NS. Overview, prevention and management of chemotherapy extravasation. World J Clin Oncol 2016; 7(1): 87-97
- URL: https://www.wjgnet.com/2218-4333/full/v7/i1/87.htm
- DOI: https://dx.doi.org/10.5306/wjco.v7.i1.87